These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 27878499)
1. Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways. Sun J; Jiang J; Lu K; Chen Q; Tao D; Chen Z Mol Cell Biochem; 2017 Feb; 426(1-2):17-26. PubMed ID: 27878499 [TBL] [Abstract][Full Text] [Related]
2. MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17. Chen JT; Yao KH; Hua L; Zhang LP; Wang CY; Zhang JJ Int J Clin Exp Pathol; 2015; 8(9):10922-8. PubMed ID: 26617808 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of EGFR inhibits growth and invasion of gastric cancer cells. Zhen Y; Guanghui L; Xiefu Z Cancer Gene Ther; 2014 Nov; 21(11):491-7. PubMed ID: 25394504 [TBL] [Abstract][Full Text] [Related]
4. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation. Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118 [TBL] [Abstract][Full Text] [Related]
5. Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action. Hu B; Meng X; Zhang Y; Hossain MM; Wu L; Zhang Y; Peng X; Zhang X Oncol Rep; 2018 Apr; 39(4):1640-1648. PubMed ID: 29393483 [TBL] [Abstract][Full Text] [Related]
6. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways. Li W; Wang D; Sun X; Zhang Y; Wang L; Suo J Int J Mol Med; 2019 Feb; 43(2):914-926. PubMed ID: 30569104 [TBL] [Abstract][Full Text] [Related]
7. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells. Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907 [TBL] [Abstract][Full Text] [Related]
8. ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells. Xu M; Zhou H; Zhang C; He J; Wei H; Zhou M; Lu Y; Sun Y; Ding JW; Zeng J; Peng W; Du F; Gong A Int J Oncol; 2016 Dec; 49(6):2520-2528. PubMed ID: 27779657 [TBL] [Abstract][Full Text] [Related]
9. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells. Blanchot-Jossic F; Jarry A; Masson D; Bach-Ngohou K; Paineau J; Denis MG; Laboisse CL; Mosnier JF J Pathol; 2005 Oct; 207(2):156-63. PubMed ID: 16041691 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation. Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008 [TBL] [Abstract][Full Text] [Related]
11. [ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad]. Chen Y; Zheng K; Chen Z; Feng H; Fang W; Huang Z Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1366-1371. PubMed ID: 30514687 [TBL] [Abstract][Full Text] [Related]
12. Association of EMP1 with gastric carcinoma invasion, survival and prognosis. Sun G; Zhao G; Lu Y; Wang Y; Yang C Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167 [TBL] [Abstract][Full Text] [Related]
13. Claudin 1 mediates tumor necrosis factor alpha-induced cell migration in human gastric cancer cells. Shiozaki A; Shimizu H; Ichikawa D; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Nako Y; Liu M; Otsuji E World J Gastroenterol; 2014 Dec; 20(47):17863-76. PubMed ID: 25548484 [TBL] [Abstract][Full Text] [Related]
14. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661 [TBL] [Abstract][Full Text] [Related]
15. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489 [TBL] [Abstract][Full Text] [Related]
16. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene. Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791 [TBL] [Abstract][Full Text] [Related]
17. A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury. Wei Z; Yu D; Bi Y; Cao Y Mol Med Rep; 2015 Jul; 12(1):63-70. PubMed ID: 25738567 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746 [TBL] [Abstract][Full Text] [Related]
19. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells]. Liu P; Wang TS; You SH; Ge HM Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873 [TBL] [Abstract][Full Text] [Related]
20. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]